BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38099666)

  • 21. Uptake of breast and cervical cancer screening in four Gulf Cooperation Council countries.
    So VHT; Channon AA; Ali MM; Merdad L; Al Sabahi S; Al Suwaidi H; Al Ajeel A; Osman N; Khoja TAM
    Eur J Cancer Prev; 2019 Sep; 28(5):451-456. PubMed ID: 30260812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
    Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
    BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rural Zulu women's knowledge of and attitudes towards Pap smears and adherence to cervical screening.
    Godfrey MAL; Mathenjwa S; Mayat N
    Afr J Prim Health Care Fam Med; 2019 Oct; 11(1):e1-e6. PubMed ID: 31588773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical screening uptake and its predictors among rural women in Malaysia.
    Gan DE; Dahlui M
    Singapore Med J; 2013 Mar; 54(3):163-8. PubMed ID: 23546031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical cancer screening after 50: near extinction?
    Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socioeconomic determinants of cervical cancer screening in Latin America.
    Soneji S; Fukui N
    Rev Panam Salud Publica; 2013 Mar; 33(3):174-82. PubMed ID: 23698136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
    Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
    Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The coverage of cervical screening in Hungary].
    Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
    Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical cancer screening among Lebanese women.
    Bou-Orm IR; Sakr RE; Adib SM
    Rev Epidemiol Sante Publique; 2018 Feb; 66(1):1-6. PubMed ID: 29249573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
    Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
    Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-reported Pap smear screening in Austria.
    Haidinger G; Waldhoer T; Vutuc C
    Wien Med Wochenschr; 2008; 158(7-8):222-6. PubMed ID: 18500476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.
    Chen YC; Liu HY; Li CY; Lee NY; Ko WC; Chou CY; Hsieh TH; Ko NY
    J Womens Health (Larchmt); 2013 Dec; 22(12):1016-22. PubMed ID: 23992102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The yield of pap smears and its characteristics in a community based setting in Saudi Arabia.
    AlBabtain FA; Hussain AN; Alsoghayer SA; Alwahbi OA; Almohaisen N; Alkhenizan AH
    Saudi Med J; 2020 Jun; 41(6):661-665. PubMed ID: 32518936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 39. Socioeconomic and cultural factors associated with pap smear screening among French women living in Réunion Island.
    Houpert R; Bendiane MK; Huiart L; Bouhnik AD; Alleaume C; Touzani R; Veronique-Baudin J; Mancini J; Joachim C; Chirpaz E
    BMC Public Health; 2024 Apr; 24(1):1125. PubMed ID: 38654197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Maura G; Chaignot C; Weill A; Alla F; Heard I
    Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.